Overview
Medtronic's Neuromodulation division is a global leader in deep brain stimulation (DBS), spinal cord stimulation, and targeted drug delivery for conditions including Parkinson's disease, essential tremor, chronic pain, and epilepsy. Their Percept PC DBS system with BrainSense technology enables real-time neural sensing during therapy delivery.
More in Neuromodulation
Latest industry news
Precision Neuroscience Raises $250M to Accelerate Brain-Computer Interface Development
2026-11-01 · Funding
Merge Labs Gets Competition as New Rival Neurotech Startup Enters the Consumer BCI Arena
2026-10-31 · Industry
Neuralink Connects to Grok AI Agent, Enabling ALS Patient to Control AI and Make Calls by Thought Alone
2026-10-30 · Product
Implanted BCIs Still Lack a Shared Safety Rulebook, and the Field Is Running Out of Time to Write One
2026-10-29 · Research
Company details
Category
⚡ Neuromodulation
Location
Dublin, Ireland
Funding
NYSE: MDT
Listed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →